Medicenna Therapeutics Quote - MDNA | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Medicenna Therapeutics Corporation (MDNA) Share Price

Medicenna Therapeutics Corporation (MDNA)

0.157

0.00

(0.00%)

Closed November 23 3:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

0.157

Bid

0.1565

Ask

0.1612

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

0.157

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

69,637,000

Dividend Yield

-

PE Ratio

-4.29

Earnings Per Share (EPS)

-0.37

Revenue

-

Net Profit

-25.47M

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically ... Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.medicenna.com

Headquarters

Toronto, Ontario, Can

Founded

-

Form 15-12G - Securities registration termination [Section 12(g)]

Form D - Notice of Exempt Offering of Securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form AW - Amendment Withdrawal Request

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form F-3/A - Registration statement by foreign private issuers: [Amend]

Form F-10POS - Post-effective amendment to a F-10EF registration

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	US$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	US$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	US$ 8.26 (89.02%)	2.03M
XCURExicure Inc	US$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	US$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	US$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	US$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	US$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	US$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	US$ 0.0201 (-0.50%)	425.38M
NVDANVIDIA Corporation	US$ 141.95 (-3.22%)	236.51M
SMCISuper Micro Computer Inc	US$ 33.15 (11.62%)	159.61M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5501 (-6.72%)	159.39M
SOUNSoundHound AI Inc	US$ 8.24 (18.05%)	107.91M

zerosnoop

zerosnoop 5 minutes ago

OIL TEST PROTOCOL

TEMPLE’S FIVE STEPS: SIMPLICITY AND ACCURACY

The setup: the complexity of Viscosity broken down to simplest elements starts with a cylinder serving as a reservoir for the oil sample placed in an environment chamber. Three meshes act as electrodes conne

Filterthenoise

Filterthenoise 5 minutes ago

zerosnoop

zerosnoop 5 minutes ago

THE VISCOSITY PROBLEM

Applied Oil Technology represents the history and rationale of a breakthrough unfolded over 20 years.

It was invented, tested exhaustively and finalised in order to serve an industry whose central and defining issue has always been the viscosity of

zerosnoop

zerosnoop 6 minutes ago

AOT EFFECT ON OIL

MOLECULAR “CARPOOLING”

A low current high voltage supply is connected to the AOT to create a strong electric field in the direction of flow.

The electric field polarizes the particles causing them to be attracted to each other forcing th

zerosnoop

zerosnoop 7 minutes ago

ASINOTROPICAL ATOMS

The AOT is the result of a multi-year research and development program conducted at Temple University with extensive design, fabrication and testing protocols involving over a dozen leading companies from all sectors of the energy industry.

Harnessin

Vexari

Vexari 7 minutes ago

Would defeat the purpose

Exposure

Is key

zerosnoop

zerosnoop 7 minutes ago

AOT APPLICATIONS

Modular. Scalable. Versatile.

Out of Temple University laboratories comes a technology offering our industry a radical new framework of change and progress.

Effective in the laboratory within the entire petroleum family, it is henceforwar

zerosnoop

zerosnoop 8 minutes ago

AOT BENEFITS

AOT enhances pipeline capacity by decreasing viscosity and potentially reducing turbulence thus lowering pipeline pressure and power consumption.

The success lies in its ability to optimize crude oil transportation, transforming both efficiency and environm

back2basics

back2basics 8 minutes ago

Kari Lake deserves a highly visible spot on Trump's team

B2B

zerosnoop

zerosnoop 8 minutes ago

OIL TEST RESULTS

Thanks to AOT and specifically Dr Tao ‘s new academic subject of Electrorheology, our industry now has the winning response to oil viscosity and the considerable complexity of sustained and efficient transportation.

Whatever the oil or product and where

zerosnoop

zerosnoop 8 minutes ago

HOW AOT WORKS

Simply and uniquely: oil flow being charged with an electric field reduces particle friction and with it the perennial challenge of viscosity.

AOT blends Directional Alignment with Nanostructural Transformation, a significant result achieved through experi

XenaLives

XenaLives 9 minutes ago

Now they are dying in the "hundreds of thousands" from the vaccines...

ddls

ddls 9 minutes ago

It hasn't done them any good has it?😎

Investors are sick of this.😎

zerosnoop

zerosnoop 9 minutes ago

When a high voltage / low current electric field reduces crude oil viscosity via solid state turn-key technology which operates sequenced processing (inline) with full remote monitoring and control, that is technology offering historic progress on an industrial scale. Bringing in a new era of energy

zerosnoop

zerosnoop 9 minutes ago

Plenty of great data on the new QS web site

https://www.qsenergy.com/

VISCOSITY REDUCTION

DRAMATIC RESULTS FOR TARGET OILS

In all tests the AOT treatment significantly reduced viscosity relative to the untreated oil samples.

3331

3331 10 minutes ago

BIEL: HUGE NEWS - #9 Most Read Board. Flagship product RecoveryRX is now available at every Veterans Administration clinic and hospital nationwide!

https://kellycovemobility.com/rrx/
An American hero gives a fantastic testimonial about Bioelectronics flagship product - Recovery

zerosnoop

zerosnoop 10 minutes ago

Have a look at these awesome Test Results. Lets see what nonsense the grubs, paid bashers, shorters & keyboard warriors come out with. Nice pictures of the PROVEN AOT on the web site. Great work by the professionals at QS in getting this done.

https://www.qsenergy.com/index.php/oil-te

3331

3331 10 minutes ago

BIEL: HUGE NEWS - #9 Most Read Board. Flagship product RecoveryRX is now available at every Veterans Administration clinic and hospital nationwide!

https://kellycovemobility.com/rrx/
An American hero gives a fantastic testimonial about Bioelectronics flagship product - Recover

MegaPirate61

MegaPirate61 10 minutes ago

Probably a moot point. If it's a 200 billion dollar asset over time the most big pharma will pay is 20b. And they will take it sooner rather than later. Maybe within the next 2 yrs.

barnyarddog

barnyarddog 10 minutes ago

XRP News: Lawyer Eyes Massive Rally Amid Trump’s US Crypto Tax Exemption

...Donald Trump has made several promises to the crypto market during his election campaigns. Besides, he also pledged to make America the crypto capital of the world, which has sparked discussions in the market.

lakers17

lakers17 11 minutes ago

https://x.com/i/status/1860528052939239479 (turn on the sound)

cojoboy

cojoboy 11 minutes ago

Anytime..my man..anytime..!!!😎😎

XenaLives

XenaLives 12 minutes ago

I agree with the "ton of money" comment...

... I disagree with the rest of your post...

.... IMO it was all about AI manipulation and had nothing to do with fictional "public welfaare".

waterchaser

waterchaser 13 minutes ago

Just like that other scam run by your bud Tony?
That pump of yours ended up lower than trips, LOL.
Good luck with HIRU… it ain’t looking good.
Agree strong by Christmas. Not Trips

BDEZ

BDEZ 14 minutes ago

sure hope so my friend..

Medicenna Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions